leisure time -WSS

leisure time

author：explore 2025-09-06 04:17:31 - browse：4

3D DNA on a sheet of paper listing nucleic acid sequences — coverage from STAT — Adobe

Ultima Genomics, an upstart some observers have called a “dark horse” in the world of DNA sequencing, will soon launch a line of high-power instruments that can read a human genome for as little as $100, the company’s leadership told STAT.

The sequencer, dubbed the UG 100, is a $1.5 million machine that can read up to 20,000 human genomes a year. The reagents required to operate the instrument cost as little as $1 per billion sequenced DNA bases; that translates to $100 per genome assuming each base in the 3-gigabase human genome is read 33 times, a common industry standard. The company plans to officially launch the product at this year’s Advances in Genome Biology and Technology meeting, which kicks off in Orlando, Fla., on Feb. 5.

The product’s cost and maximum output put it roughly in the same range as a line of high-throughput instruments launched in September 2022 by Illumina, which controls an estimated 80% of the sequencing market. But Ultima is hoping it can chip into the sequencing giant’s market share among genome centers, large clinical labs, and others with an appetite for reams of genetic data by offering lower operating costs and greater flexibility.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Test for long Covid? Researchers find new clue in blood samples

WSS

Goldman Sachs launches $650M fund for life science investments

U.K. sequencing study surfaces new findings about tumor DNA

Why psychiatrists like me stop taking insurance

My yearlong odyssey to get my son’s ADHD medication covered

AdventHealth escalates lawsuit against insurance vendor Multiplan

White House finalizes ITC's import ban of latest Apple Watches

focus

leisure time

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

Feng Zhang, Grail founder join forces on new gene editing startup

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

NIH director takes cautious approach to Biden drug pricing priority

Wildfire smoke exposes gaps in outdoor worker protections

Goldman Sachs launches $650M fund for life science investments

Sports medicine is finally prioritizing gender equality

Elizabeth Holmes banned from government health programs

Wildfire smoke exposes gaps in outdoor worker protections

My yearlong odyssey to get my son’s ADHD medication covered

hotspot

The FDA must approve intranasal treatments for anaphylaxis

My yearlong odyssey to get my son’s ADHD medication covered

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Elizabeth Holmes banned from government health programs

Research misconduct: Proposed new rules face resistance

The surgeon had a dilemma only a Nazi medical text could resolve

entertainment

focus

Wikipedia

knowledge